Search Results - "Synodinou, Maria"
-
1
Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme
Published in Journal of clinical oncology (01-04-2005)“…Surgery remains the standard treatment for glioma, followed by radiotherapy (RT) with or without chemotherapy. Despite multidisciplinary approaches, the median…”
Get full text
Journal Article -
2
Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer
Published in International journal of radiation oncology, biology, physics (01-03-2002)“…To determine the prophylactic properties of amifostine against acute and late toxicities from radiochemotherapy in patients with head-and-neck cancer. Fifty…”
Get more information
Journal Article -
3
Malignant Peripheral Nerve Sheath Tumors in Children with Neurofibromatosis Type 1
Published in Case reports in oncological medicine (01-01-2014)“…Purpose. Malignant peripheral nerve sheath tumors (MPNSTs) are rare in children and account for approximately 5–10% of all soft tissue sarcomas in adults…”
Get full text
Journal Article -
4
Differences Between Younger and Older Patients with Childhood Hodgkin Lymphoma
Published in Pediatric hematology and oncology (01-09-2013)“…From 1979 to 2006, 74 children with Hodgkin's lymphoma were treated at our center. Among them, 15 (14 boys and 1 girl) and 59 (33 boys and 26 girls) patients…”
Get full text
Journal Article -
5
Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer
Published in International journal of radiation oncology, biology, physics (15-11-2001)“…This multicenter trial investigated whether daily pretreatment with amifostine (A) could reduce the incidence of acute and late lung toxicity and esophagitis…”
Get more information
Journal Article -
6
Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer
Published in International journal of radiation oncology, biology, physics (01-10-2003)“…Radiochemotherapy (RCT) is an effective treatment for locally advanced non-small-cell lung cancer (NSCLC), but can be limited by acute and late toxicities…”
Get more information
Journal Article -
7
Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial
Published in International journal of radiation oncology, biology, physics (15-07-2003)“…To evaluate whether pretreatment with amifostine can reduce treatment-induced toxicity in patients with pelvic malignancies undergoing radiotherapy (RT). A…”
Get more information
Journal Article -
8
IMMUNE STATUS AND IMMUNE RECOVERY IN CHILDREN WITH LYMPHOMA AT THE END OF THERAPY (CHEMOTHERAPY AND/OR RADIOTHERAPY) AND IN FOLLOW-UP EVALUATIONS
Published in Pediatrics (Evanston) (01-01-2008)“…OBJECTIVE: We aimed to evaluate the immune status and immune recovery after completion of chemotherapy and/or radiotherapy in children with lymphoma. METHODS:…”
Get full text
Journal Article -
9
Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer
Published in Seminars in oncology (01-12-2003)“…Radiochemotherapy (RCT) is an effective treatment for locally advanced non-small cell lung cancer, but can be limited by acute and late toxicities…”
Get full text
Journal Article Conference Proceeding -
10